76 related articles for article (PubMed ID: 34219204)
1. The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database.
Luo Y
Clin Transl Oncol; 2022 Jan; 24(1):76-83. PubMed ID: 34219204
[TBL] [Abstract][Full Text] [Related]
2. Analysis of radiotherapy impact on survival in resected stage I/II pancreatic cancer patients: a population-based study.
Han D; Gao F; Liu JL; Wang H; Fu Q; Yang GW
BMC Cancer; 2021 May; 21(1):560. PubMed ID: 34001035
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the impact of radiotherapy and surgical treatment regimens based on the SEER database on the survival outcomes of rectal cancer patients over 70 years.
Wang W; Shen T; Wang J
Math Biosci Eng; 2024 Feb; 21(3):4463-4484. PubMed ID: 38549336
[TBL] [Abstract][Full Text] [Related]
4. Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis.
Hyder O; Dodson RM; Sachs T; Weiss M; Mayo SC; Choti MA; Wolfgang CL; Herman JM; Pawlik TM
Surgery; 2014 Jan; 155(1):85-93. PubMed ID: 23876364
[TBL] [Abstract][Full Text] [Related]
5. Stage selection for neoadjuvant radiotherapy in non-cervical esophageal cancer: A propensity score-matched study based on the SEER database.
Ma K; Yang Y; Wang S; Yang X; Lu T; Xi J; Jiang W; Zhan C; Zhu Y; Wang Q
Thorac Cancer; 2018 Sep; 9(9):1111-1120. PubMed ID: 29961955
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database.
Luo C; Fan L; Lun W; Ma M; Liang L; Yu C
J Chemother; 2024 Apr; 36(2):167-178. PubMed ID: 38481380
[TBL] [Abstract][Full Text] [Related]
7. Stratified Prognostic Comparison Between Stage IIB-IVA Cervical Adenocarcinoma and Squamous Cell Carcinoma: A SEER Database-Based Study.
Guo H; Gao S; Kong W
Int J Womens Health; 2024; 16():579-590. PubMed ID: 38596195
[TBL] [Abstract][Full Text] [Related]
8. The survival effect of neoadjuvant therapy and neoadjuvant plus adjuvant therapy on pancreatic ductal adenocarcinoma patients with different TNM stages: a propensity score matching analysis based on the SEER database.
Hu H; Xu Y; Zhang Q; Gao Y; Wu Z
Expert Rev Anticancer Ther; 2024 Apr; ():1-10. PubMed ID: 38656796
[TBL] [Abstract][Full Text] [Related]
9. Impact of Concurrent Medication Use on Pancreatic Cancer Survival-SEER-Medicare Analysis.
Beg MS; Gupta A; Sher D; Ali S; Khan S; Gao A; Stewart T; Ahn C; Berry J; Mortensen EM
Am J Clin Oncol; 2018 Aug; 41(8):766-771. PubMed ID: 28079594
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy may be the best neoadjuvant therapy modality for non-metastatic pancreatic cancer: a population based study.
Yang J; Qu X; Jiang F; Qiao HM; Zhao J; Zhang JR; Yan LJ; Zheng AJ; Ning P
Front Oncol; 2024; 14():1370009. PubMed ID: 38665957
[TBL] [Abstract][Full Text] [Related]
11. Hospital and medical care days in pancreatic cancer.
Boyd CA; Branch DW; Sheffield KM; Han Y; Kuo YF; Goodwin JS; Riall TS
Ann Surg Oncol; 2012 Aug; 19(8):2435-42. PubMed ID: 22451235
[TBL] [Abstract][Full Text] [Related]
12. First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017.
Kang MJ; Lim J; Han SS; Park HM; Park SJ; Won YJ; Kim SW
Cancer Res Treat; 2022 Jan; 54(1):208-217. PubMed ID: 34030432
[TBL] [Abstract][Full Text] [Related]
13. Role of adjuvant therapy in resected periampullary adenocarcinoma: A propensity matched case-control study.
Srivastava A; Nekarakanti PK; Kanchodu S; Srivastava S; Mishra PK; Saluja SS
Ann Hepatobiliary Pancreat Surg; 2024 Apr; ():. PubMed ID: 38600673
[TBL] [Abstract][Full Text] [Related]
14. Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma.
Wu YH; Shen SH; Wang YP; Chang NW; Lee PC; Li CP; Lan KL; Shiau CY; Hu YW; Huang PI; Hsu CX; Yen SH; Hsu SM
J Chin Med Assoc; 2024 May; 87(5):511-515. PubMed ID: 38478012
[TBL] [Abstract][Full Text] [Related]
15. Correction to: The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database.
Luo Y
Clin Transl Oncol; 2022 Jan; 24(1):159. PubMed ID: 34427886
[No Abstract] [Full Text] [Related]
16. Impact of Adjuvant Chemoradiotherapy on Survival of Resected Pancreatic Adenocarcinoma Cancer: A Surveillance, Epidemiology and End Results (SEER) Analysis.
Shi X; Peng J; Jiang H; Gao Y; Wang W; Zhou F
Front Oncol; 2021; 11():651671. PubMed ID: 34277405
[TBL] [Abstract][Full Text] [Related]
17. Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER-based analysis of 15,836 cases.
Fu N; Jiang Y; Weng Y; Chen H; Deng X; Shen B
Cancer Med; 2021 Sep; 10(17):5948-5963. PubMed ID: 34288562
[TBL] [Abstract][Full Text] [Related]
18. Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, Invasion, and Angiogenesis in Pancreatic Cancer Cells.
Huang L; Liu Y; Pan Y; Liu C; Gao H; Ren Q; Wang J; Wang H; Zhang Y; Wu A
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894684
[TBL] [Abstract][Full Text] [Related]
19. Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy.
Jan IS; Ch'ang HJ
Radiat Oncol; 2023 Aug; 18(1):137. PubMed ID: 37596627
[TBL] [Abstract][Full Text] [Related]
20. Real World Data for Pancreatic Adenocarcinoma from a Population-Based Study in France.
Badic B; Morvan M; Quénéhervé L; Bouzeloc S; Kermarrec T; Nousbaum JB; Reboux N
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
